Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres

RecruitingOBSERVATIONAL

Enrollment

350

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Severe Asthma

Interventions

DRUG

Tezepelumab

tezepelumab treatment initiated between 1st January 2023 and 31st March 2024

Trial Locations (6)

RECRUITING

Research Site, Birmingham

RECRUITING

Research Site, Liverpool

RECRUITING

Research Site, London

RECRUITING

Research Site, Newcastle

RECRUITING

Research Site, Plymouth

RECRUITING

Research Site, Southampton